Found: 13
Select item for more details and to access through your institution.
Issue Information.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 5, p. 449, doi. 10.1002/cpdd.1118
- Publication type:
- Article
Population Pharmacokinetic Modeling and Simulation of Pudexacianinium (ASP5354) for Dose Setting of a Phase 2 First‐in‐Patient Study: A Novel Imaging Agent for Intraoperative Ureter Visualization during Abdominopelvic Surgery.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 5, p. 454, doi. 10.1002/cpdd.1354
- By:
- Publication type:
- Article
A Drug‐Drug Interaction Study to Evaluate the Impact of Rimegepant on OCT2‐ and MATE1‐Mediated Transport of Metformin in Healthy Participants.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 5, p. 465, doi. 10.1002/cpdd.1352
- By:
- Publication type:
- Article
Cedirogant Population Pharmacokinetics and Pharmacodynamic Analyses of Interleukin‐17A Inhibition in Two Phase 1 Studies in Healthy Participants and Participants with Moderate to Severe Psoriasis.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 5, p. 474, doi. 10.1002/cpdd.1377
- By:
- Publication type:
- Article
Bioequivalence Study of Epalrestat for Healthy Chinese Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 5, p. 485, doi. 10.1002/cpdd.1347
- By:
- Publication type:
- Article
Two‐Part Phase 1 Study to Evaluate the Taste Profile of Novel Belumosudil Oral Suspensions and Assess the Relative Bioavailability and Food Effect of the Selected Belumosudil Oral Suspension Compared With Oral Tablet Reference in Healthy Male Participants
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 5, p. 491, doi. 10.1002/cpdd.1378
- By:
- Publication type:
- Article
Comparative Bioequivalence and Food Effect of Two Formulations of 30‐mg Nifedipine Controlled‐Release Tablets in Healthy Chinese Adults.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 5, p. 499, doi. 10.1002/cpdd.1396
- By:
- Publication type:
- Article
Relative Oral Bioavailability and Food Effects of Two Sepiapterin Formulations in Healthy Participants.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 5, p. 506, doi. 10.1002/cpdd.1363
- By:
- Publication type:
- Article
Pharmacokinetic Evaluation of the CYP3A4 and CYP2C9 Drug‐Drug Interaction of Avacopan in 2 Open‐Label Studies in Healthy Participants.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 5, p. 517, doi. 10.1002/cpdd.1389
- By:
- Publication type:
- Article
Safety, Pharmacokinetics, and Pharmacodynamics of Etrasimod: Single and Multiple Ascending Dose Studies in Healthy Adults.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 5, p. 534, doi. 10.1002/cpdd.1379
- By:
- Publication type:
- Article
Population Pharmacokinetics of the Novel Adenosine A<sub>2A</sub> Antagonist/Inverse Agonist KW‐6356 and Its Active Metabolite Following Single and Multiple Oral Administration in Healthy Individuals and Patients with Parkinson's Disease.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 5, p. 549, doi. 10.1002/cpdd.1359
- By:
- Publication type:
- Article
Safety and Pharmacokinetics of Quizartinib Combination Therapy With Standard Induction and Consolidation Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia: Results from Two Phase 1 Trials in Japan and China.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 5, p. 560, doi. 10.1002/cpdd.1353
- By:
- Publication type:
- Article
Concentration‐QTcF Modeling of Icenticaftor from a Randomized, Placebo‐ and Positive‐Controlled Thorough QT Study in Healthy Participants.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 5, p. 572, doi. 10.1002/cpdd.1374
- By:
- Publication type:
- Article